Management of Diverticular Bleeding

Introduction to PPIs and Diverticular Bleeding

The American College of Gastroenterology recommends high-dose PPI therapy for nonvariceal upper GI bleeding after endoscopic therapy, with Grade A evidence and 100% consensus from expert panels, but this is specifically for upper GI sources of bleeding 1, 2
PPIs like pantoprazole work by suppressing gastric acid secretion, which helps stabilize blood clots in the acidic environment of the upper GI tract, but have no established role in managing diverticular bleeding 1

High-quality evidence supports PPI use in nonvariceal upper GI bleeding, showing reduced rebleeding rates, need for surgery, and mortality compared to H2-receptor antagonists or placebo 2
The mechanism of diverticular bleeding involves weakened blood vessels in diverticula, not acid-related injury as seen in peptic ulcer disease 2

Diverticular bleeding is typically managed through volume resuscitation and hemodynamic stabilization, colonoscopy for diagnosis and potential endoscopic intervention, interventional radiology with angioembolization for active, severe bleeding, and surgery in cases refractory to other management approaches 2
The American College of Gastroenterology does not recommend PPIs for the management of diverticular bleeding, as they are specifically indicated for upper gastrointestinal bleeding but not lower GI bleeding from diverticula 1, 2

For variceal bleeding, PPIs may have a limited role in reducing the size of post-endoscopic variceal ligation ulcers, but this is not the primary therapy 3
No similar evidence exists for diverticular bleeding management with PPIs, and resources should instead be directed toward evidence-based interventions specific to lower GI and diverticular bleeding 1, 2